DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 26 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,426 | -34.8% | 89,700 | +9.2% | 0.00% | – |
| Q2 2023 | $354,931 | +155.4% | 82,160 | -9.5% | 0.00% | – |
| Q1 2023 | $138,962 | -5.5% | 90,825 | -2.4% | 0.00% | – |
| Q4 2022 | $147,057 | +31.3% | 93,068 | +3.1% | 0.00% | – |
| Q3 2022 | $112,000 | -45.6% | 90,254 | -11.3% | 0.00% | – |
| Q2 2022 | $206,000 | -17.6% | 101,704 | +1.8% | 0.00% | – |
| Q1 2022 | $250,000 | -33.9% | 99,942 | -1.3% | 0.00% | – |
| Q4 2021 | $378,000 | +10.2% | 101,283 | +18.4% | 0.00% | – |
| Q3 2021 | $343,000 | -9.5% | 85,570 | +0.4% | 0.00% | – |
| Q2 2021 | $379,000 | -51.3% | 85,195 | +0.2% | 0.00% | – |
| Q1 2021 | $778,000 | -36.6% | 85,026 | -29.7% | 0.00% | – |
| Q4 2020 | $1,227,000 | +147.9% | 120,989 | +3.6% | 0.00% | – |
| Q3 2020 | $495,000 | -25.5% | 116,767 | +21.8% | 0.00% | – |
| Q2 2020 | $664,000 | +1797.1% | 95,871 | +669.1% | 0.00% | – |
| Q1 2020 | $35,000 | – | 12,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,197,245 | $2,993,000 | 1.24% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 265,000 | $663,000 | 0.40% |
| COOPERMAN LEON G | 812,508 | $2,031,270 | 0.11% |
| Ikarian Capital, LLC | 221,252 | $553,000 | 0.07% |
| Shay Capital LLC | 10,000 | $25,000 | 0.00% |
| Sandy Cove Advisors, LLC | 1,200 | $3,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,603 | $52,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,269 | $3,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 1,300 | $3,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 20 | $0 | 0.00% |